SCHEMBL19984503

SCHEMBL19984503

Cc1c(C(=O)O)ccc2c1NC(=O)c1ccncc1S2(=O)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 7/20 0.37
KDM6B O15054 4/20 0.33
SLC22A12 Q96S37 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
KDM4E B2RXH2 2/20 0.33
KDM4A O75164 2/20 0.33
KDM4D Q6B0I6 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
LIG1 P18858 1/20 0.33
SIRT3 Q9NTG7 1/20 0.33
CCNC P24863 3/20 0.32
CDK8 P49336 3/20 0.32
HASPIN Q8TF76 2/20 0.32
CDK19 Q9BWU1 1/20 0.32
CA12 O43570 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19984498 0.87 ALDH1A1 (0.39) KDM4EALDH1A1KMT2AL3MBTL1CCNC
SCHEMBL19984515 0.82 TP53 (0.33) ALDH1A1MAPTCCNCCDK8
SCHEMBL29360871 0.82 KMT2A (0.42) KDM4EMEN1MAPTKMT2AL3MBTL1
SCHEMBL18666976 0.82 KMT2A (0.42) KDM4EMEN1MAPTKMT2AL3MBTL1
SCHEMBL19984564 0.78 KDM4C (0.37) KDM4CKDM6BSLC22A12TDP1KDM4E
SCHEMBL19984495 0.72 TLK2 (0.40) SLC22A12CA12CA2CA4CA7
SCHEMBL18666974 0.69 CHEK1 (0.44) MEN1ALDH1A1MAPTKMT2A
SCHEMBL18667037 0.67 LIG1 (0.42) KDM4EMEN1MAPTKMT2AL3MBTL1
SCHEMBL27336587 0.67 LIG1 (0.60) KDM4EMEN1ALDH1A1MAPTTHRB
SCHEMBL21157145 0.66 GPR3 (0.44) KDM4CKDM6BTDP1KDM4EKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2022-01-27 US disclosed
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2022-01-27 US disclosed
US-10987360-B2 Hepatitis B core protein modulators ASSEMBLY BIOSCIENCES, INC. (US) 2021-04-27 US disclosed
US-10987360-B2 Hepatitis B core protein modulators ASSEMBLY BIOSCIENCES, INC. (US) 2021-04-27 US disclosed
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2019-08-22 US disclosed
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2019-08-22 US disclosed
WO-2018053157-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES, INC. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10987360-B2 Hepatitis B core protein modulators HAVCR2, FABP1, MAVS KDM4C 3423/4885KDM6B 1519/4885SLC22A12 2821/4885
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS HAVCR2, FABP1, MAVS KDM4C 3423/4885KDM6B 1519/4885SLC22A12 2821/4885
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS HAVCR2, FABP1, MAVS KDM4C 3423/4885KDM6B 1519/4885SLC22A12 2821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.